We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Shire Sues Impax Again Over New Adderall ANDAs

Law360 (January 16, 2005, 12:00 AM EST) -- U.K. drug maker Shire Pharmaceuticals has filed a second lawsuit against U.S. generics maker Impax Labs based on an abbreviated new drug application for another dosage of best-selling attention-deficit drug Adderall XL.

Shire, which has already sued Impax over its Paragraph IV notice letter for a 30 mg generic version of Adderall XR, has filed a second complaint based on an additional Paragraph IV notice letter for a generic version of the 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.